Skip to main content

Praetorian Capital Management LLC

SEC CIK
0001337851
Latest filing
May 31, 2023

The latest 13F from Praetorian Capital Management LLC covers Q1 2023 (filed May 31, 2023) and reports no long positions. Livermore has 3 filings on Form 13F from this institution, going back to Q4 2022.

What changed in Q1 2023

Share counts compared with Q4 2022: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
0
Added
0
Reduced
0
Sold out
12
Est. −$123.0M

Top 5 holdings

Share of this quarter's portfolio value

This filing reports no long positions.

Biggest buys

New and added positions, by estimated amount bought

None this quarter.

Largest weight increases

New and added positions, by percentage points of the portfolio gained

None this quarter.

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. JOEST JOE Co
    −$34.8MSold outHistory
  2. BNOUnited States Brent Oil Fund, LP
    −$34.6MSold outHistory
  3. VALValaris Ltd
    −$23.9MSold outHistory
  4. TDWTidewater Inc
    −$11.8MSold outHistory
  5. LEELee Enterprises, Inc
    −$6.57MSold outHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. JOEST JOE Co
    −28.34 pp28.3% → 0.0%History
  2. BNOUnited States Brent Oil Fund, LP
    −28.11 pp28.1% → 0.0%History
  3. VALValaris Ltd
    −19.45 pp19.5% → 0.0%History
  4. TDWTidewater Inc
    −9.59 pp9.6% → 0.0%History
  5. LEELee Enterprises, Inc
    −5.34 pp5.3% → 0.0%History

Metrics

13F metrics for Q1 2023, computed only from the numbers in the filings. Definitions below.

Portfolio value
$0
−$123.0M (−100.0%) vs. prior quarter
Positions
0
−12 vs. prior quarter
Top 10 concentration
–
Top 10 as share of value
Turnover
0.0%
Q1 2023, one quarter
Average holding period
–
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q4 2022), so positions held before then are understated.

13F filings by quarter

2 quarters, going back to Q4 2022. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $123.0M (Q4 2022)

Q4 2022: $123.0M
Q4 2022Q1 2023
13F filings of Praetorian Capital Management LLC by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q1 2023May 31, 2023Amended0$0–vs. Q4 2022SEC
Q4 2022Feb 14, 202312$123.0MJOEBNOVAL–SEC

13D and 13G filings

Companies where Praetorian Capital Management LLC reports owning 5% or more on Schedule 13D or 13G, and its latest filings.

Current stakes of 5% or more

Praetorian Capital Management LLC does not currently report owning 5% or more of any company.

Latest filings

7 filings on file made by Praetorian Capital Management LLC or listing it as a reporting person, newest first.

Schedule 13D and 13G filings by Praetorian Capital Management LLC
CompanyFiled (ET)FilerFormStakeChangeEvent dateFiling
INMBInmune Bio, Inc.Aug 14, 202512:30 PM ETPraetorian PR LLCand 5 others13G/A3.40%921.2K shares−3.80 ppfrom 7.20%Below 5%Jun 30, 2025SEC
INMBInmune Bio, Inc.Apr 10, 202511:26 AM ETPraetorian PR LLCand 5 others13G/A7.20%1.66M shares+1.70 ppfrom 5.50%Mar 31, 2025SEC
LEELee Enterprises, IncMar 5, 20256:00 PM ETPraetorian PR LLCand 5 others13D/A4.70%291.0K shares–Below 5%Mar 3, 2025SEC
GOLDGold.com, Inc.Feb 14, 20254:16 PM ETPraetorian PR LLCand 5 others13G/A4.60%1.06M shares–Below 5%Dec 31, 2024SEC
INMBInmune Bio, Inc.Jan 15, 20253:41 PM ETPraetorian PR LLCand 5 others13G5.50%1.24M sharesNewJan 15, 2025SEC
LEELee Enterprises, IncFeb 2, 2022Praetorian Capital Management LLC13D/AOld format–––SEC
LEELee Enterprises, IncDec 8, 2021Praetorian Capital Management LLC13DOld format–New–SEC